{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:50:40Z","timestamp":1782402640265,"version":"3.54.5"},"reference-count":10,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2026,3,23]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>\n                    Presymptomatic testing (PT) for Huntington\u2019s disease (HD) has been available for over 40 years. Individuals who opt for PT are typically at a 50% risk, though in rare cases, \u201825% at-risk individuals\u2019 request to know their genetic status. Family planning is one of the main reasons why predictive testing is requested and with the availability of a direct test, new choices regarding reproduction emerged. In pregnancies, couples of whom the at-risk parent (ARP) does not want to know their own status may opt for direct testing in the 25% at-risk fetus. However, this option has a significant disadvantage: in 25% of cases, the gene expansion will be detected in the fetus, simultaneously revealing the ARP\u2019s status. Nevertheless, there is a benefit to this approach that has not yet been well exploited: adding haplotyping to a normal prenatal test outcome may find the ARP (the \u2018linking pin\u2019) no longer at risk of developing HD. We have coined the term\n                    <jats:italic>reverse haplotyping<\/jats:italic>\n                    for this approach. Data from three families in which we applied this method are presented. Our aim is to raise awareness of the full potential of DNA analysis in this context.\n                  <\/jats:p>","DOI":"10.1136\/jmg-2026-111509","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:20:41Z","timestamp":1775755241000},"page":"463-465","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Reverse haplotyping: taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington\u2019s disease"],"prefix":"10.1136","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2443-3906","authenticated-orcid":false,"given":"Emilia K","family":"Bijlsma","sequence":"first","affiliation":[{"name":"Clinical Genetics, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara T","family":"Koopmann","sequence":"additional","affiliation":[{"name":"Clinical Genetics, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3512-2468","authenticated-orcid":false,"given":"Susanne T","family":"de Bot","sequence":"additional","affiliation":[{"name":"Neurology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Losekoot","sequence":"additional","affiliation":[{"name":"Clinical Genetics, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"2026062508352762000_63.7.463.1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.30.12.982"},{"key":"2026062508352762000_63.7.463.2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<662::AID-AJMG16>3.0.CO;2-A"},{"key":"2026062508352762000_63.7.463.3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0223(199905)19:5<450::AID-PD568>3.0.CO;2-L"},{"key":"2026062508352762000_63.7.463.4","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320440122"},{"key":"2026062508352762000_63.7.463.5","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30158"},{"key":"2026062508352762000_63.7.463.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2012.01900.x"},{"key":"2026062508352762000_63.7.463.7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41431-018-0255-7","article-title":"Reverse pre-symptomatic testing for Huntington disease: double disclosure when 25% at-risk children reveal the genetic status to their parent","volume":"27","author":"Bonnard","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"2026062508352762000_63.7.463.8","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/ajmg.a.33432","article-title":"The right to ignore genetic status of late onset genetic disease in the genomic era; Prenatal testing for Huntington disease as a paradigm","volume":"152A","author":"Erez","year":"2010","journal-title":"Am J Med Genet A"},{"key":"2026062508352762000_63.7.463.9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/cge.12089","article-title":"The uptake and outcome of prenatal and pre-implantation genetic diagnosis for Huntington\u2019s disease in the Netherlands (1998-2008)","volume":"85","author":"van Rij","year":"2014","journal-title":"Clin Genet"},{"key":"2026062508352762000_63.7.463.10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/cge.12090","article-title":"Prenatal testing for Huntington\u2019s disease in the Netherlands from 1998 to 2008","volume":"85","author":"van Rij","year":"2014","journal-title":"Clin Genet"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2026-111509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:35:37Z","timestamp":1782401737000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2026-111509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":10,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6,25]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/jmg-2026-111509"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2026-111509","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}